#TILS

Hoppy

TakeAIM100

#TILS $TLSA - research note:Listing- AIM / NASDAQPrice- 57.5p52wk High- 162pMC- £92.3MIssue- 160MFreeFloat- 40%Director holding- 40%IP / Tech- Foralumab, Milciclib, Anti il-6r, StemPrintERCont. #TILS $TLSA - IP & Tech:Foralumab -

naim96 🐂

naim_aim96

#TILS $TLSA - Volume stateside approx 5m+ in terms of AIM - excellent session of churn & flushing the last of the overhang after a monster session Thursday on both

Shan90 Aim Trader

Shan90aim

I highlighted #GDR last week at 90p I am highlighting #TILS this week!2nd wave threat level is high & lock down is possible. How long can this go on for?

brendan

brendan_49

I do like that $GNCA uses autologous dendritic cells to expand their blood derived T cells. It's easy to see patient specific mutations but hard to ensure that mutations are

Sarah Constantin

s_r_constantin

My current “impractical” project is building a comprehensive list of interventions that cause >20% complete tumor regression in metastatic solid tumors. Basically, the hardest of hard modes for cancer. I